Cyteir Therapeutics, Inc. (CYT) Financials
Stock symbol CYT is outdated, potentially delisted? Maybe it is available on other exchange?
CYT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 131.0 million | 6.0 million |
| June 30, 2023 | 134.4 million | 6.6 million |
| March 31, 2023 | 139.0 million | 4.0 million |
| Dec. 31, 2022 | 153.2 million | 6.9 million |
CYT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -4.6 million | 599000 |
| June 30, 2023 | -4.1 million | 776000 |
| March 31, 2023 | -10.2 million | 1.0 million |
| Dec. 31, 2022 | -7.2 million | 869000 |
CYT Net Income
No data available :(
CYT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 129.2 million | - | 16000 |
| June 30, 2023 | 133.6 million | - | 57000 |
| March 31, 2023 | 137.2 million | - | 98000 |
| Dec. 31, 2022 | 147.1 million | - | 889000 |
CYT Shares Outstanding
CYT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 2.7 million | 2.5 million | - |
| June 30, 2023 | - | 5.4 million | 4.2 million | - |
| March 31, 2023 | - | 9.3 million | 4.1 million | - |
| Dec. 31, 2022 | 302000 | 7.5 million | 2.6 million | - |
CYT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 100000 |
| June 30, 2023 | - | 100000 |
| March 31, 2023 | - | 308000 |
| Dec. 31, 2022 | - | 326000 |
CYT
Price: $3.02
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -3.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 92100
Market Capitalization: 108.7 million